48 results on '"Wilk CM"'
Search Results
2. Clonal dynamics after allogeneic haematopoietic cell transplantation.
- Author
-
Spencer Chapman M, Wilk CM, Boettcher S, Mitchell E, Dawson K, Williams N, Müller J, Kovtonyuk L, Jung H, Caiado F, Roberts K, O'Neill L, Kent DG, Green AR, Nangalia J, Manz MG, and Campbell PJ
- Abstract
Allogeneic haematopoietic cell transplantation (HCT) replaces the stem cells responsible for blood production with those from a donor
1,2 . Here, to quantify dynamics of long-term stem cell engraftment, we sequenced genomes from 2,824 single-cell-derived haematopoietic colonies of ten donor-recipient pairs taken 9-31 years after HLA-matched sibling HCT3 . With younger donors (18-47 years at transplant), 5,000-30,000 stem cells had engrafted and were still contributing to haematopoiesis at the time of sampling; estimates were tenfold lower with older donors (50-66 years). Engrafted cells made multilineage contributions to myeloid, B lymphoid and T lymphoid populations, although individual clones often showed biases towards one or other mature cell type. Recipients had lower clonal diversity than matched donors, equivalent to around 10-15 years of additional ageing, arising from up to 25-fold greater expansion of stem cell clones. A transplant-related population bottleneck could not explain these differences; instead, phylogenetic trees evinced two distinct modes of HCT-specific selection. In pruning selection, cell divisions underpinning recipient-enriched clonal expansions had occurred in the donor, preceding transplant-their selective advantage derived from preferential mobilization, collection, survival ex vivo or initial homing. In growth selection, cell divisions underpinning clonal expansion occurred in the recipient's marrow after engraftment, most pronounced in clones with multiple driver mutations. Uprooting stem cells from their native environment and transplanting them to foreign soil exaggerates selective pressures, distorting and accelerating the loss of clonal diversity compared to the unperturbed haematopoiesis of donors., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
3. Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.
- Author
-
Park MD, Le Berichel J, Hamon P, Wilk CM, Belabed M, Yatim N, Saffon A, Boumelha J, Falcomatà C, Tepper A, Hegde S, Mattiuz R, Soong BY, LaMarche NM, Rentzeperis F, Troncoso L, Halasz L, Hennequin C, Chin T, Chen EP, Reid AM, Su M, Cahn AR, Koekkoek LL, Venturini N, Wood-Isenberg S, D'souza D, Chen R, Dawson T, Nie K, Chen Z, Kim-Schulze S, Casanova-Acebes M, Swirski FK, Downward J, Vabret N, Brown BD, Marron TU, and Merad M
- Subjects
- Animals, Humans, Mice, Hematopoiesis, Interleukin-1beta metabolism, Mice, Inbred C57BL, Pancreatic Neoplasms pathology, Pancreatic Neoplasms genetics, Pancreatic Neoplasms immunology, Signal Transduction, Aging immunology, DNA Methyltransferase 3A deficiency, Interleukin-1alpha metabolism, Interleukin-1alpha genetics, Lung Neoplasms genetics, Lung Neoplasms immunology, Lung Neoplasms pathology, Macrophages immunology, Macrophages metabolism, Myelopoiesis immunology
- Abstract
Age is a major risk factor for cancer, but how aging impacts tumor control remains unclear. In this study, we establish that aging of the immune system, regardless of the age of the stroma and tumor, drives lung cancer progression. Hematopoietic aging enhances emergency myelopoiesis, resulting in the local accumulation of myeloid progenitor-like cells in lung tumors. These cells are a major source of interleukin (IL)-1⍺, which drives the enhanced myeloid response. The age-associated decline of DNA methyltransferase 3A enhances IL-1⍺ production, and disrupting IL-1 receptor 1 signaling early during tumor development normalized myelopoiesis and slowed the growth of lung, colonic, and pancreatic tumors. In human tumors, we identified an enrichment for IL-1⍺-expressing monocyte-derived macrophages linked to age, poorer survival, and recurrence, unraveling how aging promotes cancer and offering actionable therapeutic strategies.
- Published
- 2024
- Full Text
- View/download PDF
4. Circulating myeloid-derived MMP8 in stress susceptibility and depression.
- Author
-
Cathomas F, Lin HY, Chan KL, Li L, Parise LF, Alvarez J, Durand-de Cuttoli R, Aubry AV, Muhareb S, Desland F, Shimo Y, Ramakrishnan A, Estill M, Ferrer-Pérez C, Parise EM, Wilk CM, Kaster MP, Wang J, Sowa A, Janssen WG, Costi S, Rahman A, Fernandez N, Campbell M, Swirski FK, Nestler EJ, Shen L, Merad M, Murrough JW, and Russo SJ
- Subjects
- Animals, Humans, Mice, Extracellular Space metabolism, Mice, Inbred C57BL, Nucleus Accumbens metabolism, Nucleus Accumbens pathology, Parenchymal Tissue metabolism, Single-Cell Gene Expression Analysis, Social Behavior, Social Isolation, Depressive Disorder, Major blood, Depressive Disorder, Major enzymology, Depressive Disorder, Major genetics, Depressive Disorder, Major metabolism, Matrix Metalloproteinase 8 blood, Matrix Metalloproteinase 8 deficiency, Matrix Metalloproteinase 8 genetics, Matrix Metalloproteinase 8 metabolism, Monocytes chemistry, Monocytes immunology, Monocytes metabolism, Stress, Psychological blood, Stress, Psychological genetics, Stress, Psychological immunology, Stress, Psychological metabolism
- Abstract
Psychosocial stress has profound effects on the body, including the immune system and the brain
1,2 . Although a large number of pre-clinical and clinical studies have linked peripheral immune system alterations to stress-related disorders such as major depressive disorder (MDD)3 , the underlying mechanisms are not well understood. Here we show that expression of a circulating myeloid cell-specific proteinase, matrix metalloproteinase 8 (MMP8), is increased in the serum of humans with MDD as well as in stress-susceptible mice following chronic social defeat stress (CSDS). In mice, we show that this increase leads to alterations in extracellular space and neurophysiological changes in the nucleus accumbens (NAc), as well as altered social behaviour. Using a combination of mass cytometry and single-cell RNA sequencing, we performed high-dimensional phenotyping of immune cells in circulation and in the brain and demonstrate that peripheral monocytes are strongly affected by stress. In stress-susceptible mice, both circulating monocytes and monocytes that traffic to the brain showed increased Mmp8 expression following chronic social defeat stress. We further demonstrate that circulating MMP8 directly infiltrates the NAc parenchyma and controls the ultrastructure of the extracellular space. Depleting MMP8 prevented stress-induced social avoidance behaviour and alterations in NAc neurophysiology and extracellular space. Collectively, these data establish a mechanism by which peripheral immune factors can affect central nervous system function and behaviour in the context of stress. Targeting specific peripheral immune cell-derived matrix metalloproteinases could constitute novel therapeutic targets for stress-related neuropsychiatric disorders., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
5. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders.
- Author
-
Wilk CM, Cathomas F, Török O, Le Berichel J, Park MD, Bigenwald C, Heaton GR, Hamon P, Troncoso L, Scull BP, Dangoor D, Silvin A, Fleischmann R, Belabed M, Lin H, Merad Taouli E, Boettcher S, Li L, Aubry A, Manz MG, Kofler JK, Yue Z, Lira SA, Ginhoux F, Crary JF, McClain KL, Picarsic JL, Russo SJ, Allen CE, and Merad M
- Subjects
- Humans, Brain metabolism, Myeloid Cells metabolism, Cell Differentiation, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins B-raf metabolism, Histiocytosis, Langerhans-Cell genetics, Histiocytosis, Langerhans-Cell pathology, Histiocytosis, Langerhans-Cell therapy
- Abstract
Neurodegenerative diseases (ND) are characterized by progressive loss of neuronal function. Mechanisms of ND pathogenesis are incompletely understood, hampering the development of effective therapies. Langerhans cell histiocytosis (LCH) is an inflammatory neoplastic disorder caused by hematopoietic progenitors expressing mitogen-activated protein kinase (MAPK)-activating mutations that differentiate into senescent myeloid cells that drive lesion formation. Some individuals with LCH subsequently develop progressive and incurable neurodegeneration (LCH-ND). Here, we showed that LCH-ND was caused by myeloid cells that were clonal with peripheral LCH cells. Circulating BRAFV600E
+ myeloid cells caused the breakdown of the blood-brain barrier (BBB), enhancing migration into the brain parenchyma where they differentiated into senescent, inflammatory CD11a+ macrophages that accumulated in the brainstem and cerebellum. Blocking MAPK activity and senescence programs reduced peripheral inflammation, brain parenchymal infiltration, neuroinflammation, neuronal damage and improved neurological outcome in preclinical LCH-ND. MAPK activation and senescence programs in circulating myeloid cells represent targetable mechanisms of LCH-ND., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023. Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
6. Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration.
- Author
-
Wilk CM, Cathomas F, Török O, Le Berichel J, Park MD, Heaton GR, Hamon P, Troncoso L, Scull BP, Dangoor D, Silvin A, Fleischmann R, Belabed M, Lin H, Taouli EM, Boettcher S, Manz MG, Kofler JK, Yue Z, Lira SA, Ginhoux F, Crary JF, McClain KL, Picarsic JL, Russo SJ, Allen CE, and Merad M
- Abstract
Neurodegenerative diseases (ND) are characterized by progressive loss of neuronal function. Mechanisms of ND pathogenesis are incompletely understood, hampering the development of effective therapies. Langerhans cell histiocytosis (LCH) is an inflammatory neoplastic disorder caused by hematopoietic progenitors expressing MAPK activating mutations that differentiate into senescent myeloid cells that drive lesion formation. Some patients with LCH subsequently develop progressive and incurable neurodegeneration (LCH-ND). Here, we show that LCH-ND is caused by myeloid cells that are clonal with peripheral LCH cells. We discovered that circulating BRAF V600E
+ myeloid cells cause the breakdown of the blood-brain barrier (BBB), enhancing migration into the brain parenchyma where they differentiate into senescent, inflammatory CD11a+ macrophages that accumulate in the brainstem and cerebellum. Blocking MAPK activity and senescence programs reduced parenchymal infiltration, neuroinflammation, neuronal damage and improved neurological outcome in preclinical LCH-ND. MAPK activation and senescence programs in circulating myeloid cells represent novel and targetable mechanisms of ND.- Published
- 2023
- Full Text
- View/download PDF
7. Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity.
- Author
-
Sánchez-Paulete AR, Mateus-Tique J, Mollaoglu G, Nielsen SR, Marks A, Lakshmi A, Khan JA, Wilk CM, Pia L, Baccarini A, Merad M, and Brown BD
- Subjects
- Animals, Mice, Antigens, Neoplasm, Cell Line, Tumor, Disease Models, Animal, Immunotherapy, Adoptive, Macrophages metabolism, Xenograft Model Antitumor Assays, Disease Progression, Receptors, Chimeric Antigen metabolism, T-Lymphocytes
- Abstract
Tumor-associated macrophages (TAM) are one of the most abundant cell types in many solid tumors and typically exert protumor effects. This has led to an interest in macrophage-depleting agents for cancer therapy, but approaches developed to date have had limited success in clinical trials. Here, we report the development of a strategy for TAM depletion in mouse solid tumor models using chimeric antigen receptor (CAR) T cells targeting the macrophage marker F4/80 (F4.CAR-T). F4.CAR-T cells effectively killed macrophages in vitro and in vivo without toxicity. When injected into mice bearing orthotopic lung tumors, F4.CAR-T cells infiltrated tumor lesions and delayed tumor growth comparably with PD-1 blockade, and significantly extended mouse survival. Antitumor effects were mediated by F4.CAR-T-produced IFNγ, which promoted upregulation of MHC molecules on cancer cells and tumor-infiltrating myeloid cells. Notably, F4.CAR-T promoted expansion of endogenous CD8 T cells specific for tumor-associated antigen and led to immune editing of highly antigenic tumor cell clones. Antitumor impact was also observed in mouse models of ovarian and pancreatic cancer. These studies provide proof of principle to support CAR T-cell targeting of TAMs as a means to enhance antitumor immunity., (©2022 American Association for Cancer Research.)
- Published
- 2022
- Full Text
- View/download PDF
8. Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels.
- Author
-
Wilk CM, Kovtonyuk LV, and Manz MG
- Subjects
- Animals, Mice, Receptors, Fc, Recombinant Fusion Proteins, Thrombopoietin pharmacology, Thrombopoietin therapeutic use, Transplantation Conditioning, Busulfan, Hematopoietic Stem Cell Transplantation
- Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) offers a curative treatment approach for certain benign and malignant hematologic diseases. The actual HSCT is preceded by a conditioning therapy that reduces host-vs-HSCT graft rejection and creates niche space for transplanted hematopoietic stem and progenitor cells (HSPCs). Conditioning consists of chemotherapy with or without irradiation and is a major cause of side effects in HSCT. However, reduction of the intensity of cytotoxic conditioning leads to higher rates of engraftment failure and increased rates of relapse. We here tested if the addition of an HSC cycling inducing agent during conditioning allows to diminish the dose of conditioning drugs without reducing subsequent transplanted HSC engraftment in a mouse HSCT model. The thrombopoietin receptor agonist romiplostim was shown to induce cell cycling activity in hematopoietic stem cells (HSCs). We thus tested if the addition of romiplostim to the clinically applied conditioning chemotherapy regimen cyclophosphamide and busulfan leads to increased efficacy of the chemotherapeutic regimen. We found that romiplostim not only sensitizes HSCs to chemotherapy but also enables a reduction of the main chemotherapeutic component busulfan by half while HSC engraftment levels are maintained in long-term, serial transplantation assays., (© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
9. Spatial CRISPR genomics identifies regulators of the tumor microenvironment.
- Author
-
Dhainaut M, Rose SA, Akturk G, Wroblewska A, Nielsen SR, Park ES, Buckup M, Roudko V, Pia L, Sweeney R, Le Berichel J, Wilk CM, Bektesevic A, Lee BH, Bhardwaj N, Rahman AH, Baccarini A, Gnjatic S, Pe'er D, Merad M, and Brown BD
- Subjects
- Animals, Clustered Regularly Interspaced Short Palindromic Repeats genetics, Genomics, Mice, Transforming Growth Factor beta genetics, Neoplasms genetics, Tumor Microenvironment
- Abstract
While CRISPR screens are helping uncover genes regulating many cell-intrinsic processes, existing approaches are suboptimal for identifying extracellular gene functions, particularly in the tissue context. Here, we developed an approach for spatial functional genomics called Perturb-map. We applied Perturb-map to knock out dozens of genes in parallel in a mouse model of lung cancer and simultaneously assessed how each knockout influenced tumor growth, histopathology, and immune composition. Moreover, we paired Perturb-map and spatial transcriptomics for unbiased analysis of CRISPR-edited tumors. We found that in Tgfbr2 knockout tumors, the tumor microenvironment (TME) was converted to a fibro-mucinous state, and T cells excluded, concomitant with upregulated TGFβ and TGFβ-mediated fibroblast activation, indicating that TGFβ-receptor loss on cancer cells increased TGFβ bioavailability and its immunosuppressive effects on the TME. These studies establish Perturb-map for functional genomics within the tissue at single-cell resolution with spatial architecture preserved and provide insight into how TGFβ responsiveness of cancer cells can affect the TME., Competing Interests: Declaration of interests B.D.B. and A.W. have filed a patent application related to the Pro-Code technology., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. [MDS with deletion 5q - a distinct subtype of myelodysplastic syndromes].
- Author
-
Wilk CM and Goede JS
- Subjects
- Chromosome Deletion, Humans, Lenalidomide therapeutic use, Myelodysplastic Syndromes diagnosis, Myelodysplastic Syndromes drug therapy, Myelodysplastic Syndromes genetics, Thalidomide therapeutic use
- Abstract
MDS with deletion 5q - a distinct subtype of myelodysplastic syndromes Abstract. Deletion of the long arm of chromosome 5 (del(5q)) is a recurrent anomaly in myelodysplastic syndromes associated with a distinct pathophysiology and specific treatment options. MDS with isolated del(5q) are associated with a favorable risk profile and can be treated with lenalidomide. MDS with isolated del(q) have to be distinguished from MDS with an anomaly on the long arm of chromosome 5 and more than one additional mutation turning these cases into high-risk forms of MDS.
- Published
- 2022
- Full Text
- View/download PDF
11. BRAF V600E -induced senescence drives Langerhans cell histiocytosis pathophysiology.
- Author
-
Bigenwald C, Le Berichel J, Wilk CM, Chakraborty R, Chen ST, Tabachnikova A, Mancusi R, Abhyankar H, Casanova-Acebes M, Laface I, Akturk G, Jobson J, Karoulia Z, Martin JC, Grout J, Rafiei A, Lin H, Manz MG, Baccarini A, Poulikakos PI, Brown BD, Gnjatic S, Lujambio A, McClain KL, Picarsic J, Allen CE, and Merad M
- Subjects
- Animals, Apoptosis genetics, Cell Proliferation genetics, Cellular Senescence drug effects, Cytokines metabolism, Hematopoietic Stem Cells pathology, Humans, Mice, Mice, Inbred C57BL, Mice, Transgenic, Sirolimus pharmacology, TOR Serine-Threonine Kinases antagonists & inhibitors, Cellular Senescence genetics, Histiocytosis, Langerhans-Cell genetics, Histiocytosis, Langerhans-Cell pathology, Langerhans Cells pathology, Proto-Oncogene Proteins B-raf genetics
- Abstract
Langerhans cell histiocytosis (LCH) is a potentially fatal condition characterized by granulomatous lesions with characteristic clonal mononuclear phagocytes (MNPs) harboring activating somatic mutations in mitogen-activated protein kinase (MAPK) pathway genes, most notably BRAF
V600E . We recently discovered that the BRAFV600E mutation can also affect multipotent hematopoietic progenitor cells (HPCs) in multisystem LCH disease. How the BRAFV600E mutation in HPCs leads to LCH is not known. Here we show that enforced expression of the BRAFV600E mutation in early mouse and human multipotent HPCs induced a senescence program that led to HPC growth arrest, apoptosis resistance and a senescence-associated secretory phenotype (SASP). SASP, in turn, promoted HPC skewing toward the MNP lineage, leading to the accumulation of senescent MNPs in tissue and the formation of LCH lesions. Accordingly, elimination of senescent cells using INK-ATTAC transgenic mice, as well as pharmacologic blockade of SASP, improved LCH disease in mice. These results identify senescent cells as a new target for the treatment of LCH.- Published
- 2021
- Full Text
- View/download PDF
12. Disruption of CSF-1R signaling inhibits growth of AML with inv(16).
- Author
-
Simonis A, Russkamp NF, Mueller J, Wilk CM, Wildschut MHE, Myburgh R, Wildner-Verhey van Wijk N, Mueller R, Balabanov S, Valk PJM, Theocharides APA, and Manz MG
- Subjects
- Humans, Receptor Protein-Tyrosine Kinases, Signal Transduction, Leukemia, Myeloid, Acute
- Published
- 2021
- Full Text
- View/download PDF
13. Clonal hematopoiesis in hematopoietic stem cell transplantation.
- Author
-
Wilk CM, Manz MG, and Boettcher S
- Subjects
- Cell Differentiation, Clonal Evolution genetics, Disease Management, Graft vs Host Disease etiology, Humans, Outcome Assessment, Health Care, Prognosis, Tissue Donors, Transplantation, Autologous, Transplantation, Homologous, Clonal Hematopoiesis, Hematopoietic Stem Cell Transplantation adverse effects, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism
- Abstract
Purpose of Review: Clonal hematopoiesis (CH) is characterized by the acquisition of somatic mutations and subsequent expansion of mutated hematopoietic stem and progenitor cell (HSPC) clones without clinical evidence for a hematologic neoplasm. The prevalence of CH continuously increases with age reaching double-digit percentages in individuals >60 years. CH is associated with an increased risk for hematologic neoplasms and cardiovascular disease. We will review recent efforts to investigate how CH influences patient outcomes in hematopoietic stem cell transplantation - both autologous (ASCT) and allogeneic (allo-HSCT)., Recent Findings: Donor-engrafted CH is common in allo-HSCT recipients. Apart from a higher incidence of chronic GvHD and the rare but devastating complication of donor-derived leukemia, CH does not appear to negatively impact outcomes in allo-HSCT recipients. In lymphoma patients undergoing ASCT, however, CH is associated with an excess mortality driven by therapy-related myeloid neoplasms and cardiovascular events. Interestingly, inferior overall survival in patients with CH undergoing ASCT for multiple myeloma (MM) is due to an increased rate of MM progression., Summary: CH is highly prevalent in both allo-HSCT and ASCT patients suggesting a clinically relevant but context-dependent impact on adverse outcomes. Given the current lack of therapeutic interventions, systematic screening for CH in the transplant setting is currently not indicated outside of clinical studies., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement.
- Author
-
Chanias I, Wilk CM, Benz R, Daskalakis M, Stüssi G, Schmidt A, Bacher U, Bonadies N, and On Behalf Of The Swiss Mds Study Group
- Subjects
- Adult, Humans, Immunosuppressive Agents, Myelodysplastic Syndromes drug therapy, Platelet Count, Switzerland, Delivery of Health Care, Myelodysplastic Syndromes therapy
- Abstract
The impact on health care of patients with myelodysplastic syndromes (MDS) is continuously rising. To investigate the perception of hemato-oncologists concerning the recommended MDS patient care in Switzerland, we conducted a web-based survey on diagnosis, risk-stratification and treatment. 43/309 physicians (13.9%) replied to 135 questions that were based on current guidelines between 3/2017 and 2/2018. Only questions with feedback-rates >50% were further analysed and ratios >90% defined "high agreement", 70-90% "agreement", 30-70% "insufficient agreement" and <30% "disagreement". For diagnosis, we found insufficient agreement on using flow-cytometry, classifying MDS precursor conditions, performing treatment response assessment after hypomethylating agents (HMA) and evaluating patients with suspected germ-line predisposition. For risk-stratification, we identified agreement on using IPSS-R but insufficient agreement for IPSS and patient-based assessments. For treatment, we observed disagreement on performing primary infectious prophylaxis in neutropenia but agreement on using only darbepoetin alfa in anaemic, lower-risk MDS patients. For thrombopoietin receptor agonists, insufficient agreement was found for the indication, preferred agent and triggering platelet count. Insufficient agreement was also found for immunosuppressive treatment in hypoplastic MDS and HMA dose adjustments. In conclusion, we identified areas for improvement in MDS patient care, in need of further clinical trials, information, and guiding documents.
- Published
- 2020
- Full Text
- View/download PDF
15. BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell-like histiocytosis in immune-deficient mice.
- Author
-
Rafiei A, Wilk CM, Helbling PM, Myburgh R, Saito Y, Haralambieva E, Soldini D, Chakraborty R, Merad M, Allen CE, Nombela-Arrieta C, and Manz MG
- Subjects
- Animals, Humans, Langerhans Cells, MAP Kinase Kinase 1, Mice, Histiocytosis, Histiocytosis, Langerhans-Cell genetics
- Published
- 2020
- Full Text
- View/download PDF
16. Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells.
- Author
-
Myburgh R, Kiefer JD, Russkamp NF, Magnani CF, Nuñez N, Simonis A, Pfister S, Wilk CM, McHugh D, Friemel J, Müller AM, Becher B, Münz C, van den Broek M, Neri D, and Manz MG
- Subjects
- Animals, Biomarkers, Biopsy, Bone Marrow metabolism, Bone Marrow pathology, Cell Line, Tumor, Disease Models, Animal, Gene Expression, Hematologic Neoplasms diagnosis, Hematologic Neoplasms immunology, Hematologic Neoplasms metabolism, Hematologic Neoplasms therapy, Hematopoietic Stem Cells immunology, Hematopoietic Stem Cells metabolism, Humans, Immunophenotyping, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute immunology, Leukemia, Myeloid, Acute pathology, Leukemia, Myeloid, Acute therapy, Lymphocyte Depletion, Mice, Proto-Oncogene Proteins c-kit genetics, Proto-Oncogene Proteins c-kit metabolism, Receptors, Antigen, T-Cell genetics, Receptors, Chimeric Antigen genetics, Treatment Outcome, Xenograft Model Antitumor Assays, Immunotherapy, Adoptive, Proto-Oncogene Proteins c-kit antagonists & inhibitors, Receptors, Antigen, T-Cell immunology, Receptors, Chimeric Antigen immunology, T-Lymphocytes immunology, T-Lymphocytes metabolism
- Abstract
Acute myeloid leukemia (AML) initiating and sustaining cells maintain high cell-surface similarity with their cells-of-origin, i.e., hematopoietic stem and progenitor cells (HSPCs), and identification of truly distinguishing leukemia-private antigens has remained elusive to date. To nonetheless utilize surface antigen-directed immunotherapy in AML, we here propose targeting both, healthy and malignant human HSPC, by chimeric antigen receptor (CAR) T-cells with specificity against CD117, the cognate receptor for stem cell factor. This approach should spare most mature hematopoietic cells and would require CAR T termination followed by subsequent transplantation of healthy HSPCs to rescue hematopoiesis. We successfully generated anti-CD117 CAR T-cells from healthy donors and AML patients. Anti-CD117 CAR T-cells efficiently targeted healthy and leukemic CD117-positive cells in vitro. In mice xenografted with healthy human hematopoiesis, they eliminated CD117-expressing, but not CD117-negative human cells. Importantly, in mice xenografted with primary human CD117-positive AML, they eradicated disease in a therapeutic setting. Administration of ATG in combination with rituximab, which binds to the co-expressed CAR T-cell transduction/selection marker RQR8, led to CAR T-cell depletion. Thus, we here provide the first proof of concept for the generation and preclinical efficacy of CAR T-cells directed against CD117-expressing human hematopoietic cells.
- Published
- 2020
- Full Text
- View/download PDF
17. Coronaviruses hijack the complement system.
- Author
-
Wilk CM
- Published
- 2020
- Full Text
- View/download PDF
18. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
- Author
-
Boettcher S, Wilk CM, Singer J, Beier F, Burcklen E, Beisel C, Ventura Ferreira MS, Gourri E, Gassner C, Frey BM, Schanz U, Skoda RC, Ebert BL, Brummendorf TH, Beerenwinkel N, and Manz MG
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Alleles, Clonal Evolution genetics, Colony-Forming Units Assay, DNA Mutational Analysis, Female, Hematopoietic Stem Cells cytology, Humans, Male, Middle Aged, Mutation, Prognosis, Telomere, Transplant Recipients, Transplantation, Homologous, Treatment Outcome, Young Adult, Clonal Hematopoiesis, Hematopoietic Stem Cell Transplantation mortality, Hematopoietic Stem Cells metabolism, Tissue Donors
- Abstract
Clonal hematopoiesis (CH) is associated with age and an increased risk of myeloid malignancies, cardiovascular risk, and all-cause mortality. We tested for CH in a setting where hematopoietic stem cells (HSCs) of the same individual are exposed to different degrees of proliferative stress and environments, ie, in long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their respective related donors (n = 42 donor-recipient pairs). With a median follow-up time since allo-HSCT of 16 years (range, 10-32 years), we found a total of 35 mutations in 23 out of 84 (27.4%) study participants. Ten out of 42 donors (23.8%) and 13 out of 42 recipients (31%) had CH. CH was associated with older donor and recipient age. We identified 5 cases of donor-engrafted CH, with 1 case progressing into myelodysplastic syndrome in both donor and recipient. Four out of 5 cases showed increased clone size in recipients compared with donors. We further characterized the hematopoietic system in individuals with CH as follows: (1) CH was consistently present in myeloid cells but varied in penetrance in B and T cells; (2) colony-forming units (CFUs) revealed clonal evolution or multiple independent clones in individuals with multiple CH mutations; and (3) telomere shortening determined in granulocytes suggested ∼20 years of added proliferative history of HSCs in recipients compared with their donors, with telomere length in CH vs non-CH CFUs showing varying patterns. This study provides insight into the long-term behavior of the same human HSCs and respective CH development under different proliferative conditions., (© 2020 by The American Society of Hematology.)
- Published
- 2020
- Full Text
- View/download PDF
19. Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation.
- Author
-
Bögeholz J, Russkamp NF, Wilk CM, Gourri E, Haralambieva E, Schanz U, Mueller NJ, Manz MG, and Müller AMS
- Subjects
- Antibodies, Viral, Follow-Up Studies, Humans, Measles-Mumps-Rubella Vaccine, Retrospective Studies, Hematopoietic Stem Cell Transplantation, Measles prevention & control, Mumps prevention & control, Rubella prevention & control
- Abstract
Outbreaks of viral infections, such as measles, are regularly observed and pose a serious threat to recipients of allogeneic hematopoietic cell transplantation (HCT). The questions of how long cellular and humoral protective host immunity persists, and whether donor immunity can be transferred has not been clarified. Here we present a retrospective analysis of humoral immunity-serial antibody titers against measles, mumps, and rubella-in 331 patients who underwent allogeneic HCT at our single center between 2002 and 2015. Associations between the loss of protective antibody levels and clinical patient characteristics and transplantation parameters were examined. In general, antibody protection against measles persisted longer, with 72% of patients maintaining sufficient titers at 5 years post-HCT even without revaccination, while at that time only 65% and 50% of patients had protective immunity against rubella and mumps, respectively. The great majority of donors were seropositive for all 3 viruses; however, it appeared that donor humoral immunity could not be transferred and had no impact on post-HCT serostatus. Rather, the most relevant factor for persistent protective antibody titers against measles and rubella was whether patients were born before the introduction of the respective vaccine and thus were immunized by the wild-type disease-inducing virus instead of the vaccine. Moreover, the presence of moderate and severe chronic graft-versus-host disease (GVHD) was associated with more rapid loss of immune protection. In contrast, underlying disease, intensity of the conditioning regimen, use of antithymocyte globulin, age, and graft source had no influence on antibody titers. Overall, our findings suggest that the majority of antibodies against measles, mumps, and rubella originate from residual host cells, whereas donor immune status appears to have no influence on antibody protection post-HCT., (Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
20. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.
- Author
-
Kirschner M, Maurer A, Wlodarski MW, Ventura Ferreira MS, Bouillon AS, Halfmeyer I, Blau W, Kreuter M, Rosewich M, Corbacioglu S, Beck J, Schwarz M, Bittenbring J, Radsak MP, Wilk CM, Koschmieder S, Begemann M, Kurth I, Schemionek M, Brümmendorf TH, and Beier F
- Subjects
- Adult, Dyskeratosis Congenita complications, Female, Follow-Up Studies, Germany epidemiology, Humans, Incidence, Leukemia, Myeloid, Acute epidemiology, Male, Middle Aged, Myelodysplastic Syndromes epidemiology, Prognosis, Young Adult, Biomarkers, Tumor genetics, Dyskeratosis Congenita genetics, Leukemia, Myeloid, Acute genetics, Mutation, Myelodysplastic Syndromes genetics, Telomere Shortening genetics
- Abstract
Dyskeratosis congenita (DKC) is a paradigmatic telomere disorder characterized by substantial and premature telomere shortening, bone marrow failure, and a dramatically increased risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). DKC can occur as a late-onset, so-called cryptic form, with first manifestation in adults. Somatic MDS-related mutations are found in up to 35% of patients with acquired aplastic anemia (AA), especially in patients with short telomeres. The aim of our study was to investigate whether cryptic DKC is associated with an increased incidence of MDS-related somatic mutations, thereby linking the accelerated telomere shortening with the increased risk of MDS/AML. Samples from 15 adult patients (median age: 42 years, range: 23-60 years) with molecularly confirmed cryptic DKC were screened using next-generation gene panel sequencing to detect MDS-related somatic variants. Only one of the 15 patients (7%) demonstrated a clinically relevant MDS-related somatic variant. This incidence was dramatically lower than formerly described in acquired AA. Based on our data, we conclude that clonal evolution of subclones carrying MDS-related mutations is not the predominant mechanism for MDS/AML initiation in adult cryptic DKC patients.
- Published
- 2018
- Full Text
- View/download PDF
21. Impact of oral gut decontamination on Staphylococcus aureus colonisation in patients undergoing allogeneic haematopoietic stem cell transplantation.
- Author
-
Wilk CM, Weber I, Seidl K, Rachmühl C, Holzmann-Bürgel A, Müller AMS, Kuster SP, Schanz U, and Zinkernagel AS
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Immunocompromised Host, Male, Middle Aged, Prospective Studies, Transplantation, Homologous, Treatment Outcome, Young Adult, Decontamination methods, Gastrointestinal Tract microbiology, Hematopoietic Stem Cell Transplantation, Mouth microbiology, Staphylococcal Infections drug therapy
- Abstract
Recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) are severely immunocompromised and are at increased risk of infection. In this prospective, observational, single-centre study including 110 allo-HSCT recipients, the rate of Staphylococcus aureus colonisation was reduced from 11.8% to 0% (P <0.001) following peritransplant oral gut decontamination. No invasive S. aureus infections were observed., (Copyright © 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
22. Humanised mouse models for haematopoiesis and infectious diseases.
- Author
-
Lysenko V, McHugh D, Behrmann L, Rochat MA, Wilk CM, Kovtonyuk L, Bourquin JP, Münz C, Manz MG, Speck R, and Theocharides A
- Subjects
- Animals, HIV, Herpesvirus 4, Human, Humans, Leukemia, Myeloid, Acute drug therapy, Leukemia, Myeloid, Acute physiopathology, Lymphoma physiopathology, Mice, Communicable Diseases physiopathology, Communicable Diseases therapy, Disease Models, Animal, Hematopoiesis
- Abstract
"Humanised" mouse models have emerged over past years as powerful tools for investigating human haematopoiesis and immunity. They allowed the identification of key factors for the maintenance and function of normal and leukaemic human haematopoietic stem cells. These findings have been widely used to dissect the pathogenesis of multiple myeloid and lymphoid neoplasms, such as acute myeloid leukaemia and acute lymphoblastic leukaemia. Furthermore, these models can serve as a stepping-stone to clinical trials by testing novel drugs that target leukaemic stem cells. The investigation of human immunity in vivo is also of great interest in both the context of understanding the innate and adaptive immune system and responses to viral infections with exclusive human tropism, such as Epstein-Barr virus and human immunodeficiency virus. This review focuses on recent advances in the study of human haematopoiesis and immunity in humanised mouse models, underlining their relevance and limitations.
- Published
- 2017
- Full Text
- View/download PDF
23. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
- Author
-
Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk CM, and Arndt V
- Subjects
- Aged, Aged, 80 and over, Female, History, 21st Century, Humans, Incidence, Male, Myelodysplastic Syndromes mortality, Registries, Retrospective Studies, Risk, Survival Analysis, Switzerland, Myelodysplastic Syndromes classification, Myelodysplastic Syndromes epidemiology
- Abstract
Myelodysplastic syndromes (MDS) are emerging disorders of the elderly with an increasing burden on healthcare systems. He we report on the first population-based, epidemiological analysis of patients diagnosed with MDS in Switzerland between 2001 and 2012. The aim of this study was to characterize the extent and limitations of currently available population-based, epidemiological data and formulate recommendations for future health services research. The investigated outcomes comprised trends of annual case frequency, classification of morphological subtypes, incidence, mortality and survival. Annual case frequency increased by 20% (from 263 to 315 cases per year), whereas age-standardized incidence-/mortality-rates remained stable (2.5/1.1 per 100'000 person-years). This observation reflects population growth as well as higher diagnostic awareness and not an increase of age-specific risk. However, it will inevitably influence the future prevalence of MDS and the impact on healthcare systems. Reporting of classification in MDS subtypes was poor with modest improvement from 20% to 39% and increased awareness for mainly higher-risk diseases. Relative survival for all patients at 5-years (RS) ranged between 37 and 40%. Significant better RS was found for younger compared to older higher-risk MDS patients (48% vs. 17%), reflecting the effect of allogeneic hematopoietic stem-cell transplantation. However, no survival advantage was found in elderly patients after introduction of hypomethylating agents as standard for care in this patient group. Our data is in line with results from other MDS and cancer registries. It allows formulating recommendations for future collaborative health services research on MDS patients with national and international partners., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
24. Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis.
- Author
-
Wilk CM, Heinzler N, Boquoi A, Cadeddu RP, Strapatsas T, Dienst A, Majidi F, Deenen R, Bruns I, Schroeder T, Köhrer K, Haas R, Kobbe G, and Fenk R
- Subjects
- Angiogenesis Inhibitors therapeutic use, Bone Marrow drug effects, Consolidation Chemotherapy, Fetal Hemoglobin metabolism, Hematopoietic Stem Cells drug effects, Humans, Lenalidomide, Middle Aged, Thalidomide therapeutic use, Erythropoiesis drug effects, Multiple Myeloma blood, Multiple Myeloma drug therapy, Myelopoiesis drug effects, Thalidomide analogs & derivatives
- Abstract
New drugs for the treatment of multiple myeloma (MM) comprise immunomodulatory substances such as lenalidomide and related compounds. While lenalidomide has found its way into first-line treatment as well as into relapse therapy, little is known about lenalidomide effects on normal hematopoietic stem and progenitor cells (HSPCs). In this study, we investigated whether HSPCs are influenced by lenalidomide on a phenotypic, functional and gene expression level. For that purpose, samples from patients with MM were obtained who underwent equivalent first-line treatment including induction therapy, cytotoxic stem cell mobilization and high-dose melphalan therapy followed by autologous blood stem cell transplantation and a subsequent uniform lenalidomide consolidation treatment within a prospective clinical trial. We found that after six months of lenalidomide therapy, the number of CD34(+) HSPCs decreased. Additionally, lenalidomide affects the numerical composition of hematopoietic cells in the bone marrow while it does not affect long-term HSPC proliferation in vitro. We found a significant amplification of fetal hemoglobin (HbF) expression on a transcriptional level and can confirm a stimulated erythropoiesis on a phenotypic level. These effects were accompanied by silencing of the TGF-β signaling pathway on the gene expression and protein level that is known to be amplified in active MM. However, these pleiotropic effects gave no evidence for mutagenic potential. In conclusion, lenalidomide does not exert long-term effects on proliferation of HSPCs but instead promotes erythropoiesis by shifting hemoglobin expression toward HbF and by silencing the TGF-β signaling pathway., (© 2016 UICC.)
- Published
- 2016
- Full Text
- View/download PDF
25. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
- Author
-
Geyh S, Rodríguez-Paredes M, Jäger P, Khandanpour C, Cadeddu RP, Gutekunst J, Wilk CM, Fenk R, Zilkens C, Hermsen D, Germing U, Kobbe G, Lyko F, Haas R, and Schroeder T
- Subjects
- Adult, Aged, Aged, 80 and over, Antigens, CD34 genetics, Antigens, CD34 metabolism, Calcium-Binding Proteins genetics, Calcium-Binding Proteins metabolism, Case-Control Studies, Cell Differentiation drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Culture Media, Conditioned pharmacology, Female, Hematopoiesis genetics, Humans, Intercellular Signaling Peptides and Proteins genetics, Intercellular Signaling Peptides and Proteins metabolism, Jagged-1 Protein, Leukemia, Myeloid, Acute metabolism, Leukemia, Myeloid, Acute pathology, Male, Membrane Proteins genetics, Membrane Proteins metabolism, Mesenchymal Stem Cells drug effects, Mesenchymal Stem Cells pathology, Middle Aged, Osteocalcin genetics, Osteocalcin metabolism, Osteogenesis drug effects, Phenotype, Serrate-Jagged Proteins, Signal Transduction, Stem Cell Factor genetics, Stem Cell Factor metabolism, Gene Expression Regulation, Leukemic, Leukemia, Myeloid, Acute genetics, Mesenchymal Stem Cells metabolism
- Abstract
Hematopoietic insufficiency is the hallmark of acute myeloid leukemia (AML) and predisposes patients to life-threatening complications such as bleeding and infections. Addressing the contribution of mesenchymal stromal cells (MSC) to AML-induced hematopoietic failure we show that MSC from AML patients (n=64) exhibit significant growth deficiency and impaired osteogenic differentiation capacity. This was molecularly reflected by a specific methylation signature affecting pathways involved in cell differentiation, proliferation and skeletal development. In addition, we found distinct alterations of hematopoiesis-regulating factors such as Kit-ligand and Jagged1 accompanied by a significantly diminished ability to support CD34+ hematopoietic stem and progenitor cells in long-term culture-initiating cells (LTC-ICs) assays. This deficient osteogenic differentiation and insufficient stromal support was reversible and correlated with disease status as indicated by Osteocalcin serum levels and LTC-IC frequencies returning to normal values at remission. In line with this, cultivation of healthy MSC in conditioned medium from four AML cell lines resulted in decreased proliferation and osteogenic differentiation. Taken together, AML-derived MSC are molecularly and functionally altered and contribute to hematopoietic insufficiency. Inverse correlation with disease status and adoption of an AML-like phenotype after exposure to leukemic conditions suggests an instructive role of leukemic cells on bone marrow microenvironment.
- Published
- 2016
- Full Text
- View/download PDF
26. Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.
- Author
-
Wilk CM, Fischer JC, Schieren G, Rox JM, Haas R, Rump LC, Kobbe G, and Schroeder T
- Subjects
- Adult, Allografts, Female, Graft Rejection etiology, Humans, Graft Rejection therapy, Isoantibodies, Leukemia, Myeloid, Acute therapy, Plasmapheresis, Stem Cell Transplantation, Unrelated Donors
- Published
- 2015
- Full Text
- View/download PDF
27. The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells.
- Author
-
Wilk CM, Schildberg FA, Lauterbach MA, Cadeddu RP, Fröbel J, Westphal V, Tolba RH, Hell SW, Czibere A, Bruns I, and Haas R
- Subjects
- Animals, Cell Adhesion, Female, Humans, Integrin beta1 metabolism, Male, Mice, Tetraspanin 30 metabolism, Transplantation, Homologous, Bone Marrow Transplantation, Cell Movement, Graft Survival, Hematopoietic Stem Cells metabolism, Tissue Inhibitor of Metalloproteinase-1 metabolism
- Abstract
Homing and engraftment of hematopoietic stem and progenitor cells (HSPCs) during bone marrow transplantation are critically dependent on integrins such as β1-integrin. In the present study, we show that β1-integrin and the tetraspanin CD63 form a cell surface receptor complex for the soluble serum protein tissue inhibitor of metalloproteinases-1 (TIMP-1) on human CD34⁺ HSPCs. Through binding to this receptor complex, TIMP-1 activates β1-integrin, increases adhesion and migration of human CD34⁺ cells, and protects these cells from induced apoptosis. TIMP-1 stimulation in murine bone marrow mononuclear cells also promotes migration and adhesion; this is associated with augmented homing of murine mononuclear cells and of murine LSK⁺ cells during bone marrow transplantation. These results not only indicate that TIMP-1 is conducive to HSPC homing; they also identify CD63 and β1-integrin as a TIMP-1 receptor complex on HSPCs., (Copyright © 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
28. Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes.
- Author
-
Fröbel J, Cadeddu RP, Hartwig S, Bruns I, Wilk CM, Kündgen A, Fischer JC, Schroeder T, Steidl UG, Germing U, Lehr S, Haas R, and Czibere A
- Subjects
- Adult, Aged, Aged, 80 and over, Arachidonic Acid physiology, Cell Adhesion, Cells, Cultured, Collagen physiology, Female, Humans, Male, Middle Aged, Myelodysplastic Syndromes metabolism, Protein Interaction Maps, Receptors, Cell Surface metabolism, Signal Transduction, Young Adult, Blood Platelets metabolism, Integrins physiology, Myelodysplastic Syndromes physiopathology, Platelet Aggregation, Proteome metabolism
- Abstract
Bleeding complications are a significant clinical problem in patients with myelodysplastic syndromes even at sufficient platelet counts (>50,000/μl). However, the underlying pathology of this hemorrhagic diathesis is still unknown. Here, we analyzed the platelet proteome of patients with myelodysplastic syndromes by quantitative two-dimensional difference gel electrophoresis followed by mass spectrometric protein identification. Proteins identified with lower concentrations, such as Talin-1, Vinculin, Myosin-9, Filmain-A, and Actin play critical roles in integrin αIIbβ3 signaling and thus platelet aggregation. Despite normal agonist receptor expression, calcium flux, and granule release upon activation, the activation capacity of integrin αIIbβ3 was diminished in myelodysplastic syndrome platelets. Förster resonance energy transfer analysis showed a reduced co-localization of Talin-1 to the integrin's β3-subunit, which is required for receptor activation and fibrinogen binding. In addition, platelet spreading on immobilized fibrinogen was incomplete, and platelet aggregation assays confirmed a general defect in integrin-dependent platelet aggregation in patients with myelodysplastic syndromes. Our data provide novel aspects on the molecular pathology of impaired platelet function in myelodysplastic syndromes and suggest a mechanism of defective integrin αIIbβ3 signaling that may contribute to the hemorrhagic diathesis observed in these patients.
- Published
- 2013
- Full Text
- View/download PDF
29. Prophylaxis with antipsychotic medication reduces the risk of post-operative delirium in elderly patients: a meta-analysis.
- Author
-
Teslyar P, Stock VM, Wilk CM, Camsari U, Ehrenreich MJ, and Himelhoch S
- Subjects
- Aged, Antipsychotic Agents administration & dosage, Delirium epidemiology, Humans, Length of Stay, Placebos, Postoperative Complications epidemiology, Randomized Controlled Trials as Topic, Risk, Antipsychotic Agents therapeutic use, Delirium prevention & control, Intensive Care Units, Perioperative Care methods, Postoperative Complications prevention & control, Surgical Procedures, Operative adverse effects
- Abstract
Background: Delirium commonly occurs in hospitalized elderly patients, resulting in increased morbidity and mortality. Although evidence for treatment of delirium exists, evidence supporting pharmacologic prevention of delirium in high risk patients is limited., Objective: This review examined whether delirium in at-risk patients can be prevented with antipsychotic prophylaxis in the inpatient setting., Data Sources: A systematic literature review of articles from January 1950 to April 2012 was conducted in PubMed, PsychInfo, and Cochrane Controlled Trials and databases., Study Selection: Five studies (1491 participants) met our inclusion criteria for analysis. Medication administered included haloperidol (three studies), risperidone (one study), and olanzapine (1 study). All five studies examined older post-surgical patients, spanning five different countries., Data Extraction: Only RCTs of antipsychotic medication used to prevent delirium were included. Key words used in the search were: "delirium," "encephalopathy," "ICU psychosis," "prevention," and "prophylaxis." Studies had to include a validated method of diagnosing delirium. Data analysis was performed using the Metan command in Stata (Stata Corp LP, College Station, TX)., Results: The pooled relative risk of the five studies resulted in a 50% reduction in the relative risk of delirium among those receiving antipsychotic medication compared with placebo (RR(95% CI): 0.51 (0.33-0.79; heterogeneity, p < 0.01, random effects model). Examination of the funnel plot did not indicate publication bias., Conclusions: Although few studies have examined prophylactic use of antipsychotics, this analysis suggests that perioperative use of prophylactic antipsychotics may effectively reduce the overall risk of postoperative delirium in elderly patients., (Copyright © 2013 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
30. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
- Author
-
Bruns I, Cadeddu RP, Brueckmann I, Fröbel J, Geyh S, Büst S, Fischer JC, Roels F, Wilk CM, Schildberg FA, Hünerlitürkoglu AN, Zilkens C, Jäger M, Steidl U, Zohren F, Fenk R, Kobbe G, Brors B, Czibere A, Schroeder T, Trumpp A, and Haas R
- Subjects
- Animals, Blotting, Western, Bone Marrow metabolism, Case-Control Studies, Cell Adhesion, Cell Cycle, Cell Differentiation, Cell Movement, Cell Proliferation, Cells, Cultured, Female, Flow Cytometry, Fluorescent Antibody Technique, Gene Expression Profiling, Hematopoietic Stem Cells metabolism, Humans, Immunoenzyme Techniques, Male, Megakaryocyte-Erythroid Progenitor Cells metabolism, Mesenchymal Stem Cells metabolism, Mesenchymal Stem Cells pathology, Mice, Mice, Inbred NOD, Multiple Myeloma genetics, Oligonucleotide Array Sequence Analysis, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Antigens, CD34 metabolism, Biomarkers metabolism, Bone Marrow pathology, Hematopoietic Stem Cells pathology, Megakaryocyte-Erythroid Progenitor Cells pathology, Multiple Myeloma metabolism, Multiple Myeloma pathology
- Abstract
Multiple myeloma (MM) is a clonal plasma cell disorder frequently accompanied by hematopoietic impairment. We show that hematopoietic stem and progenitor cells (HSPCs), in particular megakaryocyte-erythrocyte progenitors, are diminished in the BM of MM patients. Genomic profiling of HSPC subsets revealed deregulations of signaling cascades, most notably TGFβ signaling, and pathways involved in cytoskeletal organization, migration, adhesion, and cell-cycle regulation in the patients. Functionally, proliferation, colony formation, and long-term self-renewal were impaired as a consequence of activated TGFβ signaling. In accordance, TGFβ levels in the BM extracellular fluid were elevated and mesenchymal stromal cells (MSCs) had a reduced capacity to support long-term hematopoiesis of HSPCs that completely recovered on blockade of TGFβ signaling. Furthermore, we found defective actin assembly and down-regulation of the adhesion receptor CD44 in MM HSPCs functionally reflected by impaired migration and adhesion. Still, transplantation into myeloma-free NOG mice revealed even enhanced engraftment and normal differentiation capacities of MM HSPCs, which underlines that functional impairment of HSPCs depends on MM-related microenvironmental cues and is reversible. Taken together, these data implicate that hematopoietic suppression in MM emerges from the HSPCs as a result of MM-related microenvironmental alterations.
- Published
- 2012
- Full Text
- View/download PDF
31. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
- Author
-
Singh R, Cadeddu RP, Fröbel J, Wilk CM, Bruns I, Zerbini LF, Prenzel T, Hartwig S, Brünnert D, Schroeder T, Lehr S, Haas R, and Czibere A
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Caspase 3 metabolism, Cell Cycle Proteins metabolism, Cell Differentiation, Cell Survival, Cloning, Molecular, Flow Cytometry, Fos-Related Antigen-2 metabolism, Gene Expression Profiling methods, Gene Expression Regulation, Neoplastic, Genetic Vectors, HL-60 Cells, Humans, JNK Mitogen-Activated Protein Kinases metabolism, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute metabolism, Nuclear Proteins metabolism, Proto-Oncogene Proteins c-jun metabolism, RNA Interference, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods, Sulindac therapeutic use, Transcriptional Activation, Apoptosis, Diclofenac therapeutic use, Leukemia, Myeloid, Acute drug therapy, Sulindac analogs & derivatives, Transcription Factor AP-1 metabolism
- Abstract
Acute myeloid leukemia is a heterogeneous disease with varying genetic and molecular pathologies. Non-steroidal anti-inflammatory drugs (NSAIDs) have been proven to possess significant anti-proliferative potential in various cancer cells in vitro and in vivo. Hence, treatment with these agents can be utilized to study disease specific anti-proliferative pathways. In this study, a total number of 42 bone marrow derived CD34(+) selected de novo AML patient samples and the AML cell lines THP-1 and HL-60 were treated with the NSAIDs Sulindac sulfide and Diclofenac. We analyzed viability, apoptosis, differentiation and addressed the molecular mechanisms involved. We found a consistent induction of apoptosis and to some extent an increased myeloid differentiation capacity in NSAID treated AML cells. Comprehensive protein and gene expression profiling of Diclofenac treated AML cells revealed transcriptional activation of GADD45α and its downstream MAPK/JNK pathway as well as increased protein levels of the caspase-3 precursor. This pointed towards a role of the c-Jun NH(2)-terminal kinase (JNK) in NSAID mediated apoptosis that we found indeed to be dependent on JNK activity as addition of a specific JNK-inhibitor abrogated apoptosis. Furthermore, the AP-1 transcription factor family members' c-Jun, JunB and Fra-2 were transcriptionally activated in NSAID treated AML cells and re-expression of these transcription factors led to activation of GADD45α with induction of apoptosis. Mechanistically, we demonstrate that NSAIDs induce apoptosis in AML through a novel pathway involving increased expression of AP-1 heterodimers, which by itself is sufficient to induce GADD45α expression with consecutive activation of JNK and induction of apoptosis.
- Published
- 2011
- Full Text
- View/download PDF
32. No, it is not possible to be schizophrenic yet neuropsychologically normal.
- Author
-
Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, and Buchanan RW
- Subjects
- Adult, Case-Control Studies, Female, Humans, Intelligence, Male, Middle Aged, Neuropsychological Tests standards, Psychiatric Status Rating Scales statistics & numerical data, Verbal Behavior physiology, Wechsler Scales statistics & numerical data, Cognition Disorders physiopathology, Neuropsychological Tests statistics & numerical data, Schizophrenia physiopathology, Schizophrenic Psychology
- Abstract
Cognitive impairment is well documented in schizophrenia, though some reports have been interpreted to suggest that it is possible to have schizophrenia without neuropsychological impairment. The authors tested this by comparing the neuropsychological profiles of closely matched patients with schizophrenia and healthy comparison participants. Sixty-four patients with schizophrenia and 64 healthy comparison cases, matched to within 3 Full-Scale IQ points, were tested using the Wechsler Adult Intelligence Scale (3rd ed.; D. Wechsler, 1997b) and the Wechsler Memory Scale (3rd ed.; D. Wechsler, 1997c). Neuropsychological profiles for these groups were markedly different, with the group of patients with schizophrenia exhibiting performance deficits in memory and speeded visual processing but superior verbal comprehension and perceptual organization relative to the group of healthy comparison participants matched on Full-Scale IQ. Thus, scoring in the normal range does not preclude neuropsychological abnormality in schizophrenia, confirming that neuropsychological impairment is a core feature of the illness., (Copyright (c) 2005 APA, all rights reserved.)
- Published
- 2005
- Full Text
- View/download PDF
33. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.
- Author
-
Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, and Buchanan RW
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Reproducibility of Results, Severity of Illness Index, Time Factors, Cognition Disorders diagnosis, Cognition Disorders epidemiology, Neuropsychological Tests, Schizophrenia epidemiology
- Abstract
Background: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a brief, standardized cognitive screening instrument that assesses several domains of interest and offers an efficient approach to screening for cognitive impairment in schizophrenia (SC). Prior studies have established the clinical validity and test-retest reliability of the RBANS in SC., Aims: The purpose of the current study was to guide clinical interpretation by providing normative data for the use of the RBANS as a measure of cognitive impairment in SC. We also sought to evaluate the role of demographic factors and to present percentile data accordingly., Methods: 575 patients (391 male, 184 female) meeting the diagnostic criteria for SC or schizoaffective disorder were recruited from 4 inpatient (n=117) and 6 outpatient (n=458) sites in 2 different mental health treatment systems. All participants were administered the RBANS according to standardized instructions and a subgroup of 242 patients were also administered the Wide Range Achievement Test (3rd Edition) (WRAT-3) Reading subtest., Results: RBANS Total Scale score for patients with SC was approximately 2 standard deviations below the normal mean, was approximately 1 standard deviation below WRAT-3 Reading scores, and expected patterns of impairment were observed: measures of language and visuospatial ability were preserved relative to those of memory and attention. Aside from weak associations with Language (0.139) and Attention (0.112), age was not significantly associated with RBANS Index scores (which are age adjusted in healthy controls). Education was significantly associated with all RBANS scores and one-way ANOVA indicates that those with more than high school education scored consistently higher than the other two groups (less than and equal to a complete high school education). Normative tables with age and education based percentiles are presented., Conclusions: The RBANS is an efficient screening tool for assessing cognitive impairment in patients with SC thereby making it a useful instrument for clinical and research applications.
- Published
- 2004
- Full Text
- View/download PDF
34. The family pictures test as a measure of impaired feature binding in schizophrenia.
- Author
-
Gold JM, Poet MS, Wilk CM, and Buchanan RW
- Subjects
- Adult, Analysis of Variance, Female, Humans, Male, Middle Aged, Neuropsychological Tests statistics & numerical data, Schizophrenic Psychology, Wechsler Scales statistics & numerical data, Memory Disorders physiopathology, Pattern Recognition, Visual physiology, Schizophrenia physiopathology
- Abstract
We investigated the use of the Family Pictures test from the Wechsler Memory Scale III as a measure of the ability to bind the multiple features of a complex visual scene in a study group of 77 patients with schizophrenia and 44 healthy controls. Patients demonstrated impaired recall of all scene features as well as a reduction in the number of features recalled for each remembered character. Secondary analyses using patients and controls matched for character recall also showed reduced feature binding in the patient group. Such feature binding deficits likely implicate hippocampal dysfunction, consistent with neuroimaging evidence of structural and functional compromise of the medial temporal lobe in schizophrenia.
- Published
- 2004
- Full Text
- View/download PDF
35. Assessment of depression prevalence in rural Uganda using symptom and function criteria.
- Author
-
Bolton P, Wilk CM, and Ndogoni L
- Subjects
- Adult, Comorbidity, Female, Humans, Male, Prevalence, Reproducibility of Results, Uganda epidemiology, Acquired Immunodeficiency Syndrome epidemiology, Depressive Disorder, Major diagnosis, Depressive Disorder, Major epidemiology, HIV Infections epidemiology, Rural Population statistics & numerical data, Surveys and Questionnaires
- Abstract
Background: We sought to assess the prevalence of major depression in a region of sub-Saharan Africa severely affected by HIV, using symptom and functional criteria as measured with locally validated instruments., Method: Six hundred homes in the Masaka and Rakai districts of southwest Uganda were selected by weighted systematic random sampling. A locally validated version of the depression section of the Hopkins Symptom Check List (DHSCL) and a community-generated index of functional impairment were used to interview 587 respondents., Results: Of respondents, 21% were diagnosed with depression using three of the five DSM-IV criteria (including function impairment) compared with 24.4% using symptom criteria alone. Increased age and lower educational levels are associated with a greater risk for depression; however, a gender effect was not detected., Conclusions: Most community-based assessments of depression in sub-Saharan Africa based on the DSM-IV have used symptom criteria only. We found that expanding criteria to more closely match the complete DSM-IV is feasible, thereby making more accurate assessments of prevalence possible. This approach suggests that major depression and associated functional impairment are a substantial problem in this population.
- Published
- 2004
- Full Text
- View/download PDF
36. General and specific cognitive deficits in schizophrenia.
- Author
-
Dickinson D, Iannone VN, Wilk CM, and Gold JM
- Subjects
- Adult, Case-Control Studies, Factor Analysis, Statistical, Female, Generalization, Psychological physiology, Humans, Male, Memory physiology, Middle Aged, Multivariate Analysis, Neural Networks, Computer, Verbal Learning physiology, Wechsler Scales statistics & numerical data, Cognition classification, Cognition Disorders etiology, Schizophrenia complications
- Abstract
Background: It is controversial whether the cognitive deficit in schizophrenia is better characterized as generalized or as reflecting relatively independent deficits in different cognitive domains. The issue has implications for assessment practice, intervention design, and the exploration of schizophrenia genetics., Methods: We used a specialized structural equation modeling approach, single common factor analysis, to explore the relative importance of generalized versus independent cognitive deficits in schizophrenia. Eighteen subtest scores from the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale-III were included in the analysis. We analyzed these data for 97 schizophrenia or schizoaffective disorder outpatients and 87 healthy control subjects., Results: Approximately two thirds of the overall effect of a schizophrenia diagnosis on cognitive performance was mediated through a single common factor. The Wechsler subtest scores showed almost uniformly strong relationships with this factor. The independent associations of group status with the subtest scores were smaller in magnitude and only selectively significant., Conclusions: The relatively greater magnitude of illness effects mediated through the common factor in this analysis, compared with the specific, independent effects, suggests that a generalized cognitive deficit is a core feature of schizophrenia.
- Published
- 2004
- Full Text
- View/download PDF
37. Working memory for visual features and conjunctions in schizophrenia.
- Author
-
Gold JM, Wilk CM, McMahon RP, Buchanan RW, and Luck SJ
- Subjects
- Adult, Analysis of Variance, Female, Humans, Male, Memory Disorders diagnosis, Perceptual Disorders diagnosis, Random Allocation, Severity of Illness Index, Memory Disorders etiology, Perceptual Disorders etiology, Schizophrenia complications, Visual Perception physiology
- Abstract
The visual working memory (WM) storage capacity of patients with schizophrenia was investigated using a change detection paradigm. Participants were presented with 2, 3, 4, or 6 colored bars with testing of both single feature (color, orientation) and feature conjunction conditions. Patients performed significantly worse than controls at all set sizes but demonstrated normal feature binding. Unlike controls, patient WM capacity declined at set size 6 relative to set size 4. Impairments with subcapacity arrays suggest a deficit in task set maintenance: Greater impairment for supercapacity set sizes suggests a deficit in the ability to selectively encode information for WM storage. Thus, the WM impairment in schizophrenia appears to be a consequence of attentional deficits rather than a reduction in storage capacity.
- Published
- 2003
38. Local perceptions of the mental health effects of the Uganda acquired immunodeficiency syndrome epidemic.
- Author
-
Wilk CM and Bolton P
- Subjects
- Acquired Immunodeficiency Syndrome ethnology, Adult, Black People, Comorbidity, Data Collection methods, Depressive Disorder diagnosis, Depressive Disorder ethnology, Ethnicity, Female, Humans, Male, Medicine, Traditional, Prevalence, Public Opinion, Stress Disorders, Post-Traumatic diagnosis, Stress Disorders, Post-Traumatic ethnology, Uganda epidemiology, Acquired Immunodeficiency Syndrome epidemiology, Black or African American psychology, Attitude to Health ethnology, Depressive Disorder epidemiology, Disease Outbreaks statistics & numerical data, Stress Disorders, Post-Traumatic epidemiology
- Abstract
Despite much attention in developed countries, little is known about the relationship between mental health problems and the human immunodeficiency virus (HIV) in Africa. The objectives of the current study were a) to investigate how people in an African community severely affected by HIV view the mental health effects of the epidemic and b) to use these data to investigate the local construct validity of the Western concepts of depression and posttraumatic stress disorder. Ethnographic methods-free listing and key-informant interviews-were used among participants from the Rakai and Masaka districts of southwest Uganda. Participants described two independent depression-like syndromes (Yo'kwekyawa and Okwekubaziga) resulting from the HIV epidemic. No syndromes similar to posttraumatic stress disorder were detected. We conclude that local people recognize depression syndromes and consider them pertinent consequences of the HIV epidemic.
- Published
- 2002
- Full Text
- View/download PDF
39. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.
- Author
-
Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, and Buchanan RW
- Subjects
- Adolescent, Adult, Confidence Intervals, Female, Humans, Male, Middle Aged, Neuropsychological Tests standards, Psychometrics, Psychotic Disorders diagnosis, Psychotic Disorders psychology, Reproducibility of Results, Schizophrenic Psychology, Sensitivity and Specificity, Wechsler Scales statistics & numerical data, Cognition Disorders diagnosis, Neuropsychological Tests statistics & numerical data, Schizophrenia diagnosis
- Abstract
Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group., Method: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days., Results: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups., Conclusions: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale-Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.
- Published
- 2002
- Full Text
- View/download PDF
40. Familial cosegregation of affective disorder and Hailey-Hailey disease.
- Author
-
Körner J, Rietschel M, Nöthen MM, Wilk CM, Bauer R, Propping P, and Möller HJ
- Subjects
- Bipolar Disorder psychology, Chromosome Deletion, Chromosome Mapping, Humans, Male, Middle Aged, Pemphigus, Benign Familial psychology, Phenotype, Sex Chromosome Aberrations genetics, Y Chromosome, Bipolar Disorder genetics, Pemphigus, Benign Familial genetics
- Abstract
We report on a family with co-occurrence of affective disorder and Hailey-Hailey disease in two brothers and the mother. The putative chromosomal locus of Hailey-Hailey disease, which is a rare dominantly inherited dermatosis, may be a promising candidate region for genetic studies in affective disorder.
- Published
- 1993
- Full Text
- View/download PDF
41. Rhodococcus luteus and Rhodococcus erythropolis chronic endophthalmitis after lens implantation.
- Author
-
von Below H, Wilk CM, Schaal KP, and Naumann GO
- Subjects
- Aged, Aged, 80 and over, Endophthalmitis pathology, Female, Humans, Postoperative Complications, Actinomycetales Infections, Endophthalmitis microbiology, Lenses, Intraocular, Rhodococcus
- Published
- 1991
- Full Text
- View/download PDF
42. [Postoperative infections in systemic immunocompromising diseases. A study of 6 patients].
- Author
-
Bialasiewicz AA, Wilk CM, and Ruprecht KW
- Subjects
- Aged, Aged, 80 and over, Anti-Bacterial Agents, Bacteria drug effects, Bacteria isolation & purification, Conjunctiva microbiology, Drug Therapy, Combination administration & dosage, Endophthalmitis microbiology, Endophthalmitis surgery, Eye Enucleation, Female, Follow-Up Studies, Humans, Lenses, Intraocular, Male, Microbial Sensitivity Tests, Middle Aged, Opportunistic Infections microbiology, Opportunistic Infections surgery, Reoperation, Retinal Detachment surgery, Surgical Wound Infection microbiology, Surgical Wound Infection surgery, Vitrectomy, Endophthalmitis diagnosis, Eye Diseases surgery, Opportunistic Infections diagnosis, Surgical Wound Infection diagnosis
- Abstract
Advances of therapeutic strategies in the management of critically ill patients have resulted in an increased life expectancy and more frequent presentations to ophthalmic surgeons. Six patients with postoperative endophthalmitis after elective intraocular surgery suffering from Sharp-syndrome, metastasizing antrum carcinoma, granulomatous vasculitis and immunosuppressive therapy, agranulocytosis, silico-tuberculosis and chronic lymphatic leukemia revealed traditionally pathogenic agents (Proteus mirabilis, P. aeruginosa, enterococci, coagulase-negative Staph). Two patients had to be enucleated, one turned blind and three had a visual acuity 5/100 to 20/60. In our hands prognosis for successful therapy in immunodeficient patients seems worse than in otherwise healthy persons. Painstaking evaluation of history, medical work-up, conjunctival swabs and application of bactericidal topical antibiotics preoperatively and perioperatively are particularly important in these patients.
- Published
- 1991
- Full Text
- View/download PDF
43. Immunohistochemical characterization of epithelial cells in human lacrimal glands. I. Normal major and accessory lacrimal glands.
- Author
-
Vigneswaran N, Wilk CM, Heese A, Hornstein OP, and Naumann GO
- Subjects
- Actins metabolism, Antibodies, Monoclonal, Antibody Specificity, Epithelium metabolism, Humans, Immunoenzyme Techniques, Keratins metabolism, Lacrimal Apparatus cytology, Lactoferrin metabolism, Muramidase metabolism, S100 Proteins metabolism, Vimentin metabolism, Biomarkers, Lacrimal Apparatus metabolism
- Abstract
Expression patterns of cytokeratins (CKs), actin, lactoferrin (Lf), lysozyme (Ly), vimentin, and S-100 protein were immunohistochemically examined in paraffin sections from eight normal major and accessory lacrimal glands (LGs). Luminal duct cells and a number of secretory cells stained with the antibodies (ABs) KL1 and Pkk1 (CK 7, 8, 17, 18), while basal duct and myoepithelial cells reacted with the AB 34 beta E12 (CK 5). Myoepithelial cells expressing CK 5 and actin were restricted to acini and intralobular ducts, and their number was greater in major LGs than accessory ones. Lf and Ly were found in 50%-75% of acini and intralobular ducts. Vimentin was absent in parenchyma of LGs. S-100 protein reaction was observed in a number of acinar and luminal duct cells of major LGs whereas epithelia of accessory LGs remained negative. Distribution patterns of CKs, Lf, and Ly in major and accessory LGs are identical. The difference with respect to the number of myoepithelial cells as well as S-100 protein reactivity between major and accessory LGs reactivity appeared to be relevant to the differences in their secretory mechanisms and local environment.
- Published
- 1990
- Full Text
- View/download PDF
44. Immunohistochemical characterization of epithelial cells in human lacrimal glands. II. Inflammatory and neoplastic lesions of lacrimal glands.
- Author
-
Wilk CM, Vigneswaran N, Heese A, Hornstein OP, and Naumann GO
- Subjects
- Actins metabolism, Female, Humans, Immunoenzyme Techniques, Infant, Keratins metabolism, Lactoferrin metabolism, Male, Middle Aged, Muramidase metabolism, S100 Proteins metabolism, Vimentin metabolism, Biomarkers, Dacryocystitis metabolism, Eye Neoplasms metabolism, Lacrimal Apparatus metabolism, Lacrimal Apparatus Diseases metabolism
- Abstract
The distribution of cytokeratins (CK), actin, lactoferrin (Lf), lysozyme (Ly), vimentin and S-100 protein was immunohistochemically investigated in paraffin-embedded specimens of five inflammatory and five neoplastic lesions of lacrimal glands (LGs). Atrophic acini in dacryoadenitis reacted with antibodies (ABs) KL1 and Pkk1 (CK 7, 8, 17, 18) in a manner similar to ducts. Apart from myoepithelial cells and some luminal-duct cells, the remaining epithelia in dacryoadenitis were negative with AB 34 beta E12 (CK 5). The number of AB HHF35 (actin)-positive myoepithelial cells was not altered in dacryoadenitis. Epithelia in dacryoadenitis reacted weakly but consistently with Lf while revealing weak and inconsistent staining for Ly. Vimentin was negative in epithelial cells in dacryoadenitis except in one case. S-100 protein was detected only in epithelia of inflammatory major LGs. Epimyoepithelial islands in lymphoepithelial proliferation reacted variably for CKs, Lf, Ly and vimentin and remained negative for actin and S-100. In pleomorphic adenomas, neoplastic cells showing duct-like differentiation (luminal) reacted consistently with CK 7, 8, 17, 18 and S-100 protein and inconsistently with CK 5, Lf and Ly but remained negative for actin and vimentin. Other neoplastic cells (ovoid/peripheral cells) stained consistently for CK 5, vimentin and S-100 protein and focally for CK 7, 8, 17, 18, actin, Lf and Ly. Spindle-form neoplastic cells found in the stroma exhibited vimentin and S-100 protein and, less frequently, actin. Determination of these antigens in pleomorphic LG adenomas may help to evaluate their prognosis.
- Published
- 1990
- Full Text
- View/download PDF
45. [Fulminant gas gangrene panophthalmia following perforating scleral injury].
- Author
-
Wilk CM, Ruprecht KW, and Lang GK
- Subjects
- Adolescent, Clostridium perfringens isolation & purification, Eye Enucleation, Eye Foreign Bodies complications, Eye Injuries, Penetrating pathology, Gas Gangrene surgery, Humans, Male, Panophthalmitis surgery, Vitreous Body injuries, Eye Injuries, Penetrating complications, Gas Gangrene pathology, Panophthalmitis pathology, Sclera injuries
- Abstract
A 13-year-old boy developed Clostridium perfringens panophthalmitis due to a penetrating scleral injury. The characteristic symptoms were unusually severe periocular pain, lid edema, decreased motility and protrusion of the eye, severe conjunctival chemosis, pus covering the conjunctiva and cornea, green-brown hypopyon, gas bubbles in the anterior chamber, and amaurosis within 60 hours. In view of the patient's ocular status and impaired general condition enucleation was unavoidable. The results of laboratory workups are reported in addition to the clinical and ophthalmologic findings.
- Published
- 1989
- Full Text
- View/download PDF
46. [Changes in the indications status for keratoplasty (Erlangen, 1964-1986)].
- Author
-
Lang GK, Wilk CM, and Naumann GO
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Germany, West, Humans, Infant, Male, Middle Aged, Corneal Diseases surgery, Corneal Transplantation
- Published
- 1988
47. [Bilateral acute confluent disseminated choroiditis in Borrelia burgdorferi infection].
- Author
-
Wilk CM, Bialasiewicz AA, Ruprecht KW, and Naumann GO
- Subjects
- Adult, Antibodies, Bacterial analysis, Borrelia immunology, Female, Fluorescein Angiography, Humans, Male, Retinal Detachment diagnosis, Borrelia Infections diagnosis, Choroiditis diagnosis
- Abstract
Two patients with bilateral extensive confluent choroidal lesions, exudative retinal detachments, positive lyme serology and a typical history are documented: A 32-year-old woman presented 14 days after a "flu-like" illness with bilateral acute extensive choroidal lesions and exudative retinal detachments (OD from 5 to 8:30 o'clock, OS from 5 to 8 o'clock, both including the macula) accompanied by a mild lymphocytic meningitis. The laboratory work-up revealed increased serum and CSF titers of antibodies against Borrelia burgdorferi (Lyme immunofluorescent test (IFT) and Lyme-IgM IFT) which declined after a 14-day treatment with doxycycline (200 mg/d), CSF titers non-detectable (serum IgG: from 1:640 to 1:320, serum IgM: from 1:40 to 1:20). A distinct improvement with visual acuity increasing from OD 0.2/OS 0.3 p to OD/OS 0.8 p was observed after seven days of treatment. A 40-year-old man with a 14-day history of tick-bite developed the same, though more severe ocular findings and a lymphocytic meningitis. The serological work-up revealed increased antibody titers against Borrelia burgdorferi (ELISA); the IgM titer was normal. After a 10-day treatment with penicillin, antibody titers against the spirochete decreased slightly and the patient's neurologic and ophthalmologic status improved dramatically. Five weeks after admission visual acuity was OD/OS 0.5 (compared to OD/OS 0.1) and has remained at 0.8 p (OD/OS) since the ninth week after onset. The clinical course of the disease and the decreasing lyme serology strongly suggest an infection with Borrelia burgdorferi. The authors propose thorough laboratory work-ups including tests for Lyme disease in selected patients with diffuse choroidal lesions.
- Published
- 1989
- Full Text
- View/download PDF
48. Optimum dentistry through oral photography.
- Author
-
Wilk CM
- Subjects
- Humans, Dentistry, Photography
- Published
- 1973
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.